Document is current

Article History

Received: 8 June 2024

Accepted: 9 December 2024

First Online: 22 January 2025

Declarations

:

: Not applicable.

: Not applicable.

: We received no support from any organisation for the submitted work. MAH and JM are a co-applicants of the RELEASE and RELEASE+ trials in Australia, funded by the Medical Research Future Fund (MRFF) and the National Health and Medical Research Council (NHMRC). MAH receives royalties from Wiley Blackwell for the Maudsley Deprescribing Guidelines. MAH is co-founder and consultant for Outro Health, a digital clinic aiming to help patients to stop unnecessary antidepressant medication. MAH has been paid honoraria by several NHS Trusts for grand rounds presentations, and by Salomon’s University, the University of Arizona, and the University of Washington. JM is a co-investigator on REDUCE (programme grant studying discontinuation of antidepressants) and Chief Investigator on RADAR (programme grant to explore antipsychotic reduction and discontinuation). JM has been paid honoraria by University of Basel, Alberta Psychiatric Association, and Case Western University. JM receives royalties from Palgrave Macmillan and PCCS Books for three books about psychiatric drugs. JM is a co-chair person (unfunded position) of Critical Psychiatry Network. MPH receives royalties from Palgrave Macmillan for a book about antidepressants. We report no other relationships or activities that could appear to have influenced the submitted work.

: Not applicable.